David Bowton to Asthma
This is a "connection" page, showing publications David Bowton has written about Asthma.
Connection Strength
0.827
-
Bowton DL, Dmitrienko AA, Israel E, Zeiher BG, Sides GD. Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma. J Asthma. 2005 Feb; 42(1):65-71.
Score: 0.186
-
Bowton DL, Seeds MC, Bass DA. Eosinophil cationic protein concentration in saliva does not correlate with eosinophil cationic protein concentration in sputum. Chest. 2003 Mar; 123(3 Suppl):372S.
Score: 0.163
-
Balkrishnan R, Christensen DB, Bowton DL. Self-reported health status, prophylactic medication use, and healthcare costs in older adults with asthma. J Am Geriatr Soc. 2002 May; 50(5):924-9.
Score: 0.154
-
Balkrishnan R, Anderson RT, Bowton D. Self-reported health status predictors of healthcare services utilization and charges in elderly asthmatic patients. J Asthma. 2000 Aug; 37(5):415-23.
Score: 0.136
-
Seeds MC, Peachman KK, Bowton DL, Sivertson KL, Chilton FH. Regulation of arachidonate remodeling enzymes impacts eosinophil survival during allergic asthma. Am J Respir Cell Mol Biol. 2009 Sep; 41(3):358-66.
Score: 0.061
-
Hite RD, Seeds MC, Bowton DL, Grier BL, Safta AM, Balkrishnan R, Waite BM, Bass DA. Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction. . 2005 Apr; 288(4):L610-7.
Score: 0.045
-
Seeds MC, Bowton DL, Hite RD, Gyves JI, Bass DA. Human eosinophil group IID secretory phospholipase A2 causes surfactant dysfunction. Chest. 2003 Mar; 123(3 Suppl):376S-7S.
Score: 0.041
-
Surette ME, Koumenis IL, Edens MB, Tramposch KM, Clayton B, Bowton D, Chilton FH. Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma: a randomized, placebo-controlled, parallel-group, prospective trial. Clin Ther. 2003 Mar; 25(3):972-9.
Score: 0.041